| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $250.7M | +14.5% | -0.5% |
| Cost of Revenue | $46.0M | +5.5% | -1.3% |
| Gross Profit | $204.7M | +16.7% | -0.4% |
| R&D Expense | $39.6M | -1.6% | +5.0% |
| SG&A Expense | $24.1M | -8.1% | +2.8% |
| Operating Income | $64.3M | +98.0% | +4.2% |
| Pre-tax Income | $66.6M | +112.2% | +16.1% |
| Income Tax | $11.5M | +106.4% | +33.9% |
| Net Income | $55.1M | +113.5% | +13.0% |
| EPS (Basic) | $0.76 | +111.1% | +11.8% |
| EPS (Diluted) | $0.75 | +114.3% | +11.9% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $540.6M | +11.8% | +35.7% |
| Accounts Receivable | $234.6M | +80.2% | +9.3% |
| Inventory | $12.4M | +0.2% | -13.9% |
| Current Assets | $856.8M | +21.0% | +23.8% |
| Total Assets | $2.32B | +6.7% | +6.8% |
| Current Liabilities | $442.6M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $142.3M | — | — |
| Capital Expenditures | $6.9M | — | — |
| Investing Cash Flow | -$17.4M | — | — |
| Financing Cash Flow | -$47.3M | — | — |
| Free Cash Flow | $135.4M | — | — |
| +15.9% |
| Total Liabilities | $680.4M | +12.9% | +4.0% |
| Stockholders' Equity | $1.64B | +4.3% | +7.9% |